Brain-Scan AI could spot Parkinson's without costly PET imaging
NCT ID NCT04334902
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial tested a software called mPDia that uses MRI brain scans to help doctors diagnose neurodegenerative parkinsonism, a group of movement disorders including Parkinson's disease. The study involved 221 adults and compared mPDia's accuracy to standard PET scans. The goal was to see if this AI tool could provide a simpler, more widely available diagnostic option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mPDia clinical decision support software (device)
What this could lead to
If successful, mPDia could offer a faster, more accessible way to diagnose parkinsonism using standard MRI instead of expensive PET scans.
What could go wrong
This is a retrospective study, not a prospective trial, so real-world performance may differ. The software's accuracy depends on MRI quality and may not replace PET scans in all cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIAGNOSES DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, South Korea
-
Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul, South Korea
-
Cha Medical Center
Gyeonggi-do, South Korea
-
Gachon University Gil Medical Center
Incheon, South Korea
-
Gangnam Severance Hospital
Seoul, South Korea
-
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, South Korea
-
Hallym University Sacred Heart Hospital
Gyeonggi-do, South Korea
-
Korea University Ansan Hospital
Gyeonggi-do, South Korea
-
Korea University Guro Hospital
Seoul, South Korea
-
KyungHee University Medical Center
Seoul, South Korea